1. |
Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology, 2004, 40(3):652-659.
|
2. |
Lata J, Hulek P, Vanasek T. Management of acute variceal bleeding. Dig Dis, 2003, 21(1):6-15.
|
3. |
García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med, 2010, 362(25):2370-2379.
|
4. |
Koizumi J, Hashimoto T, Myojin K, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices:use of CTguided foam sclerotherapy to optimize technique. AJR Am J Roentgenol, 2012, 199(1):200-207.
|
5. |
Tiuca N, Sztogrin W. The news of treatment of variceal upper gastrointestinal bleeding. J Med Life, 2011, 4(4):395-398.
|
6. |
Iwatsuki S, Starzl TE, Todo S, et al. Liver transplantation in the treatment of bleeding esophageal varices. Surgery, 1988, 104(4):697-705.
|
7. |
de Franchis R, Dell, Era A, Iannuzzi F. Diagnosis and treatment of portal hypertension. Dig Liver Dis, 2004, 36(12):787-798.
|
8. |
Bismuth H, Adam R, Raccuia JS.肝脏移植治疗门静脉高压症.德国医学, 1996, 13(3):157-159.
|
9. |
俞军, 张武, 张珉, 等.肝移植治疗门静脉高压上消化道出血的疗效分析.中国普外基础与临床杂志, 2013, 20(1):24-28.
|
10. |
Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet, 2014, 383(9930):1749-1761.
|
11. |
Machicao VI, Balakrishnan M, Fallon MB. Pulmonary complications in chronic liver disease. Hepatology, 2014, 59(4):1627-1637.
|
12. |
Schraufnagel DE, Kay JM. Structural and pathologic changes in the lung vasculature in chronic liver disease. Clin Chest Med, 1996, 17(1):1-15.
|
13. |
Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome:Impact of liver transplantation. Hepatology, 2005, 41(5):1122-1129.
|
14. |
Krowka MJ, Mandell MS, Ramsay MA, et al. Hepatopulmonary syndrome and portopulmonary hypertension:a report of the multicenter liver transplant database. Liver Transpl, 2004, 10(2):174-182.
|
15. |
Gupta S, Castel H, Rao RV, et al. Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transplant, 2010, 10(2):354-363.
|
16. |
Krowka MJ, Wiesner RH, Heimbach JK. Pulmonary contraindications, indications and MELD exceptions for liver transplantation:a contemporary view and look forward. J hepatol, 2013, 59(2):367-374.
|
17. |
Iyer VN, Swanson KL, Cartin-Ceba RA, et al. Hepatopulmonary syndrome:Favorable outcomes in the MELD exception era. Hepatology, 2013, 57(6):2427-2435.
|
18. |
Sulieman BM, Hunsicker LG, Katz DA, et al. OPTN policy regarding prioritization of patients with hepatopulmonary syndrome:does it provide equitable organ allocation? Am J Transplant, 2008, 8(5):954-964.
|
19. |
Krowka MJ, Swanson KL, Frantz RP, et al. Portopulmonary hypertension:Results from a 10-year screening algorithm. Hepatology, 2006, 44(6):1502-1510.
|
20. |
Rodríguez-Roisin R, Krowka MJ, Hervé P, et al. ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J, 2004, 24(5):861-880.
|
21. |
Kawut SM, Krowka M, Trotter JF, et al. Clinical risk factors for portopulmonary hypertension. Hepatology, 2008, 48(1):196-203.
|
22. |
Krowka MJ, Plevak DJ, Findlay JY, et al. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl, 2000, 6(4):443-450.
|
23. |
Sussman N, Kaza V, Barshes N, et al. Successful liver transplantation following medical management of portopulmonary hypertension:a single-center series. Am J Transplant, 2006, 6(9):2177-2182.
|
24. |
Malagari K, Nikita A, Alexopoulou E, et al. Cirrhosis-related intrathoracic disease. Imaging features in 1038 patients. Hepatogastroenterology, 2005, 52(62):558-562.
|
25. |
Xiol X, Tremosa G, Castellote J, et al. Liver transplantation in patients with hepatic hydrothorax. Transpl Int, 2005, 18(6):672-675.
|
26. |
D'Amico G, Pasta L, Morabito A, et al. Competing risks and prognostic stages of cirrhosis:a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther, 2014, 39(10):1180-1193.
|